Latest News

NeoCG (ECG technology from WSU)

April 11, 2016



NeoCG is an improved screening/diagnostic tool for cardiovascular illnesses.  Currently the ECG is the sole primary screening/diagnostic tool.  The NeoCG delivers an increase in the precision of diagnosis enabling a reductions in the number of hospitalisations and a reduction in fatalities due to limited cardiac diagnoses. The current Electrocardiography market is worth more that US$1.5Bn p.a., with maintenance contracts of around the same value.  Two major Australian hospitals have invited clinical trials of NeoCG. 

Please reload

Recent Posts
Please reload

Please reload

Search By Tags
Please reload

Follow Innovyz
  • Facebook Basic Square
  • Twitter Basic Square
  • LinkedIn Social Icon

Our intensive 9-month programs are unique in the world of business incubators – we ensure that ideas lead the opportunity rather than simply support investment.


  • Incubator

  • Commercialisation Program

  • Startup Consultant

  • Accelerator

Innovyz supports CO-HAB - A first class, full featured, cost-effective, collaborative, coworking space for companies who aspire to be BIG

Special thanks to our collaboration partners:

1 Tonsley Blvd, Tonsley, Adelaide, Australia | FAQ | Email: | Phone: +61 448 053 024

* Incubator * Commercialisation Program * Startup Consultants * Accelerator *

Copyright Innovyz 2018. All rights reserved | Press Notes | Website Terms of Use | ACN: 148 989 360 | We respect your privacy. Please review our Privacy Policy for more information.

  • YouTube - Black Circle
  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon